References

Adzu, B., M. Garba, A. Haruna, M. Maman, C. Wambebe and K. Gamaniel, 2001. Effect of niprisan on single oral dose pharmacokinetics of paracetamol in rats. Eur. J. Drug Metab. Pharmacokinet., 26: 201-204.
PubMed  |  

Ali, B.H., Z. Cheng, G. El Hadrami, A.K. Bashir and Q.A. McKellar, 1996. Comparative pharmacokinetics of paracetamol (acetaminophen) and its sulphate and glucuronide metabolites in desert camels and goats. J. Vet. Pharmacol. Ther., 19: 238-244.
CrossRef  |  

Allegaert, K., B.J. Anderson, G. Naulaers, J. Hoon and R. Verbesselt et al., 2004. Intravenous paracetamol (Propacetamol) pharmacokinetics in term and preterm neonates. Eur. J. Clin. Pharmacol., 60: 191-197.
CrossRef  |  

Allegaert, K., C.D. van der Marel, A. Debeer, M Pluim and R.A. van Lingen et al., 2004. Pharmacokinetics of single dose intravenous propacetamol in neonates: Effect of gestational age. Arch. Dis. Childhood, 89: F25-F28.
CrossRef  |  

Aramaki, S., E. Suzuki, O. Ishidaka, A. Momose and K. Umemura, 1991. Pharmacokinetics of caffeine and its metabolites in horses after intravenous, intramuscular or oral administration. Chem. Pharm. Bull., 39: 2999-3002.
PubMed  |  

Babalola, C.P., F.A. Oladimeji and M.N. Femi-Oyewo, 2004. Pharmacokinetics and saliva secretion of paracetamol in healthy male Nigerians. West Afr. J. Med., 23: 10-14.
PubMed  |  

Bannwarth, B. and F. Pehourcq, 2003. Pharmacologic basis for using paracetamol: Pharmacokinetic and pharmacodynamic issues. Drugs, 63: 5-13.
PubMed  |  

Bock, K.W., J. Wiltfang, R. Blume, D. Ullrich and J. Bircher, 1987. Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking. Eur. J. Clin. Pharmacol., 31: 677-683.
CrossRef  |  

Boothe, D.M., J.M. Cullen, J.A. Calvin, W.L. Jenkins, S.A. Brown, R.A. Green and D.E. Corrier, 1994. Antipyrine and caffeine dispositions in clinically normal dogs and dogs with progressive liver disease. Am. J. Vet. Res., 55: 254-261.
PubMed  |  

Danielson, T.J. and L.R. Golsteyn, 1996. Systemic clearance and demethylation of caffeine in sheep and cattle. Drug Metab. Dispos., 24: 1058-1061.
PubMed  |  

De Graves, F.J., D.C. Ruffin, S.H. Duran, J.S. Spano, E.M. Whatley, J. Schumacher and M.G. Riddell, 1995. Pharmacokinetics of caffeine in lactating dairy cows. Am. J. Vet. Res., 56: 619-622.
PubMed  |  

De Wildt, S.N., G.L. Kearns, J.S. Leeder and J.N. van den Anker, 1999. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin. Pharmacokinet, 36: 439-452.
PubMed  |  

Depelchin, B.O., S. Bloden, C. Michaux and M. Ansay, 1988. Effect of age, sex and breed on antipyrine disposition in calves. Res. Vet. Sci., 44: 135-138.
PubMed  |  

Engelking, L.R., G.T. Blyden, J. Lofstedt and D.J. Greenblatt, 1987. Pharmacokinetics of antipyrine, acetaminophen and lidocaine in fed and fasted horses. J. Vet. Pharmacol. Ther., 10: 73-82.
CrossRef  |  

Flouvat, B., A. Leneveu, S. Fitoussi, B. Delhotal-Landes and A. Gendron, 2004. Bioequivalence study comparing a new paracetamol solution for injection and propacetamol after single intravenous infusion in healthy subjects. Int. J. Clin. Pharmacol. Ther., 42: 50-57.
PubMed  |  

Hahn, T.W., S.W. Henneberg, R.J. Holm-Knudsen, K. Eriksen, S.N. Rasmussen and M. Rasmussen, 2000. Pharmacokinetic of rectal paracetamol after repeated dosing in children. Br. J. Anaesth, 85: 512-519.
PubMed  |  

Higaki, K., M. Ishii, H. Esumi, M. Kanayama, K.I. Ogawara and T. Kimura, 2003. Pharmacokinetic analysis of factors determining elimination pathways for sulfate and glucuronide metabolites of xenobiotics II: Studies with isolated perfused rat liver. Xenobiotica, 33: 1097-1108.
PubMed  |  

Janus, K. and B. Grochowina, 2006. Effects of age on the pharmacokinetics of paracetamol in calves (In Polish). Medycyna Wet, 62: 193-196.

Janus, K. and B. Grochowina, 2006. Trials to evaluate the biotransformation activity of the liver in calves using a simplified paracetamol test (In Polish). Medycyna Wet, 62: 1084-1086.

Janus, K. and J. Suszycka, 1996. Effect of age on the pharmacokinetics of antipyrine in calves. Res. Vet. Sci., 60: 234-237.
CrossRef  |  

Janus, K., A. Bartos, M. Kozłowska, S. Suszycki, J. Antoszek and M. Muszczynski, 2007. Pharmacokinetics of caffeine in Black-and-White breed and BW x HF cross-breed calves (In Polish). Medycyna Wet, 63: 696-699.

Janus, K., B. Grochowina, J. Antoszek, S. Suszycki and Z. Muszczynski, 2003. The effect of food or water deprivation on paracetamol pharmacokinetics in calves. J. Vet. Pharmacol. Ther., 6: 291-296.
CrossRef  |  

Kawalek, J.C. and K.R. El-Said, 1990. Maturational development of drug-metabolizing enzymes in sheep. Am. J. Vet. Res., 51: 1736-1741.
PubMed  |  

Kearns, G.L. and M.D. Reed, 1989. Clinical pharmacokinetics in infants and children. A reppraisal. Clin. Pharmacokinet., 17: 29-52.
PubMed  |  

Kennedy, J.M., N.M. Tyers and A.K. Davey, 2003. The influence of morphine on the absorption of paracetamol from various formulations in subjects in the supine position, as assessed by TDx measurement of salivary paracetamol concentrations. J. Pharm. Pharmacol., 55: 1345-1350.
PubMed  |  

Lakin, K.M., E.W. Zorian, M.M. Kac, G.M. Aleksandrowa and G.N. Efremowa, 1997. Determination of narcotic substances in saliva in clinical and experimental study (In Russian). Farmakol. Toksikol., 50: 93-97.

Li, X.D., S.Q. Xia, Y. Lv, P. He, J. Han and M.C. Wu, 2004. Conjugation metabolism of acetaminophen and bilirubin in extrahepatic tissues of rats. Life Sci., 74: 1307-1315.
CrossRef  |  

Linday, L.A., D.J. Greenblatt, M.P. Warren, J.S. Harmatz, R. De Cresce, C. Cicalese and B.W. Le Duc, 1991. Changes in salivary antipyrine pharmacokinetics during adolescence, correlated with age, hormonal levels and Tanner stage. Dev. Pharmacol. Ther., 16: 194-200.
PubMed  |  

Mansor, S.M., G. Edwards, P.J. Roberts and S.A. Ward, 1991. The effect of malaria infection on paracetamol disposition in the rat. Biochem. Pharmacol., 41: 1707-1711.
CrossRef  |  

McNamara, P.J., D. Burgio and S.D. Yoo, 1991. Pharmacokinetics of acetaminophen, antipyrine and salicylic acid in the lactating and nursing rabbit, with model predictions of milk to serum concentration ratios and neonatal dose. Toxicol. Applied Pharmacol., 109: 149-160.
CrossRef  |  

Meffin, P.J., R.L. Williams, T.F. Blaschke and M. Rowland, 1977. Application of salivary concentration data to pharmacokinetic studies with antipyrine. J. Pharm. Sci., 66: 135-137.
CrossRef  |  

Miller, R.P., R.J. Roberts and L.J. Fischer, 1976. Acetaminophen elimination kinetics in neonates, children and adults. Clin. Pharmacol. Ther., 19: 284-294.
PubMed  |  

Miners, J.O., K.J. Lillywhite, K. Yoovathaworn, M. Pongmarutai and D.J. Birkett, 1990. Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver microsomes. Biochem. Pharmacol., 40: 595-600.
CrossRef  |  

Monshouwer, M., R.F. Witkamp, A. Pijpers, J.H. Verheijden and A.S. van Miert, 1994. Dose-dependent pharmacokinetic interaction between antipyrine and paracetamol in vivo and in vitro when administered as a cocktail in pig. Xenobiotica, 24: 347-355.
PubMed  |  

Monshouwer, M., R.F. Witkamp, S.M. Nijmeijer, A. Pijpers, J.H. Verheijden and A.S. van Miert, 1995. Selective effects of a bacterial infection (Actinobacillus pleuropneumoniae) on the hepatic clearances of caffeine, antipyrine, paracetamol and indocyanine green in the pig. Xenobiotica, 25: 491-499.
PubMed  |  

Peck, K., K.L. Mealey, N.S. Matthews and T.S. Taylor, 1997. Comparative pharmacokinetics of caffeine and three metabolites in clinically normal horses and donkeys. Am. J. Vet. Res., 58: 881-884.
PubMed  |  

Posti, J., 1999. Drug concentration in plasma and saliva-physiological and phamacokinetic examination. Pharm. Acta Helv., 54: 191-199.

Wasfi, I.A., N.S. Boni, M. Elghazali, A.A. Abdel Hadi, A.M. Almuhrami, I.M. Barezaig and N.A. Alkatheeri, 2000. The pharmacokinetics, metabolism and urinary detection time of caffeine in camels. Res. Vet. Sci., 69: 69-74.
CrossRef  |  

Welch, R.M., R.L. De Angelis, M. Wingfield and T.W. Farmer, 1975. Elimination of antipyrine from saliva as a measure of metabolism in man. Clin. Pharmacol. Ther., 18: 249-258.
PubMed  |  

Wynne, H.A., L.H. Cope, B. Herd, M.D. Rawlins, O.F. James and K.W. Woodhouse, 1990. The association of age and frailty with paracetamol conjugation in man. Age Ageing, 19: 419-424.
PubMed  |  

Zylber-Katz, E., L. Granit and M. Levy, 1984. Relationship between caffeine concentrations in plasma and saliva. Clin. Pharmacol. Ther., 36: 133-137.
PubMed  |